Medical Device and Diagnostics (MDD) Companies face multiple challenges throughout the Asian Pacific area in both the commercial and operational arenas. The Asia-Pacific MDD market is estimated at between US$55-60 billion (approximately 25% of the global market) and is growing at twice the global rate. Moreover, there is no “one fit all” model since each country and every franchise enjoys a different level of maturity. As a result, manufacturer needs are very specific to the segments and countries they operate in.
Leveraging our history and experience in the region, Zuellig Pharma is partnering with various stakeholders to develop unique and efficient supply chain solutions. We focus on delivering tailor-made solutions with the objective of improving visibility, traceability and accuracy. Improving supply chain is paramount to reducing waste and improving order-to-cash cycles and benefits both manufacturers and downstream customers. In conjunction with our innovative logistics solutions we offer a comprehensive range of commercial set ups that support our Principals’ needs for consolidation and increased focus on commercial compliance, local quality assurance and regulatory requirements.
We actively engage with a wide spectrum of MDD companies enabling our tailor made distribution and supply chain models to cover most MDD franchises.
Tell us about your needs and learn how our MDD experts can help.